Genetically modified stem cells for the treatment of neurological diseases

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 3, 2012, Pages 170-1181

  Mitrecic, Dinko ^a   Nicaise, Charles ^b   Klimaschewski, Lars ^c   Gajovic, Srecko ^a   Bohl, Delphine ^d   Pochet, Roland ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d INSTITUT PASTEUR   (France)

Author keywords

Brain tumors; Epilepsy; Gene transfection; Induced pluripotent stem cells; IPSCs; Neurodegenerative diseases; Review; Stem cells; Stroke

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CELL ADHESION MOLECULE; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; NEUROGENIN 1; NEUROTROPHIN; NEUROTROPHIN 3; NOGGIN; OCTAMER TRANSCRIPTION FACTOR 4; SOMATOMEDIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; ASTROCYTOSIS; AXONAL INJURY; BRAIN CELL; CELL PROLIFERATION; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; DNA METHYLATION; DNA MODIFICATION; DOPAMINERGIC NERVE CELL; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; GENETIC MANIPULATION; GLIA CELL; HUMAN; HUNTINGTON CHOREA; MOTONEURON; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE REGENERATION; NEURAL CREST CELL; NEUROEPITHELIUM; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OPTIC NERVE INJURY; PARKINSON DISEASE; PHASE 1 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; SCHWANN CELL; SOMATIC CELL; STEM CELL; STEM CELL GENE THERAPY; STEM CELL TRANSPLANTATION;

ANIMALIA;

EID: 84883609388     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: 10.2741/e449     Document Type: Article

References (109)

1. B. M. Demaerschalk, H. M. Hwang and G. Leung: US cost burden of ischemic stroke: a systematic literature review. Am J Manag Care, 16, 525-533 (2010)
2. B. Blum and N. Benvenisty: The tumorigenicity of human embryonic stem cells. Adv Cancer Res, 100, 133-158 (2008) (Pubitemid 351932182)
3. D. Mitrecic, S. Gajovic and R. Pochet: Toward the treatments with neural stem cells: experiences from amyotrophic lateral sclerosis. Anat Rec (Hoboken), 292, 1962-1967 (2009)
4. K. Takahashi and S. Yamanaka: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676 (2006) (Pubitemid 44233629)
5. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda and S. Yamanaka: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861-872 (2007) (Pubitemid 350138099)
6. G. Amabile and A. Meissner: Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med, 15, 59-68 (2009)
7. J. Yu, M. A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J. L. Frane, S. Tian, J. Nie, G. A. Jonsdottir, V. Ruotti, R. Stewart, Slukvin, II and J. A. Thomson: Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917-1920 (2007)
8. M. Wernig, J. P. Zhao, J. Pruszak, E. Hedlund, D. Fu, F. Soldner, V. Broccoli, M. Constantine-Paton, O. Isacson and R. Jaenisch: Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A, 105, 5856-5861 (2008) (Pubitemid 351758462)
9. A. Gore, Z. Li, H. L. Fung, J. E. Young, S. Agarwal, J. Antosiewicz-Bourget, I. Canto, A. Giorgetti, M. A. Israel, E. Kiskinis, J. H. Lee, Y. H. Loh, P. D. Manos, N. Montserrat, A. D. Panopoulos, S. Ruiz, M. L. Wilbert, J. Yu, E. F. Kirkness, J. C. Izpisua Belmonte, D. J. Rossi, J. A. Thomson, K. Eggan, G. Q. Daley, L. S. Goldstein and K. Zhang: Somatic coding mutations in human induced pluripotent stem cells. Nature, 471, 63-67 (2011)
10. R. Lister, M. Pelizzola, Y. S. Kida, R. D. Hawkins, J. R. Nery, G. Hon, J. Antosiewicz-Bourget, R. O'Malley, R. Castanon, S. Klugman, M. Downes, R. Yu, R. Stewart, B. Ren, J. A. Thomson, R. M. Evans and J. R. Ecker: Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature, 471, 68-73 (2011)
11. S. M. Hussein, N. N. Batada, S. Vuoristo, R. W. Ching, R. Autio, E. Narva, S. Ng, M. Sourour, R. Hamalainen, C. Olsson, K. Lundin, M. Mikkola, R. Trokovic, M. Peitz, O. Brustle, D. P. Bazett-Jones, K. Alitalo, R. Lahesmaa, A. Nagy and T. Otonkoski: Copy number variation and selection during reprogramming to pluripotency. Nature, 471, 58-62 (2011)
12. B. W. Carey, S. Markoulaki, J. Hanna, K. Saha, Q. Gao, M. Mitalipova and R. Jaenisch: Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci U S A, 106, 157-162 (2009)
13. K. Kaji, K. Norrby, A. Paca, M. Mileikovsky, P. Mohseni and K. Woltjen: Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 458, 771-775 (2009)
14. K. H. Narsinh, F. Jia, R. C. Robbins, M. A. Kay, M. T. Longaker and J. C. Wu: Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc, 6, 78-88 (2010)
15. K. Okita, M. Nakagawa, H. Hyenjong, T. Ichisaka and S. Yamanaka: Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322, 949-953 (2008)
16. L. Warren, P. D. Manos, T. Ahfeldt, Y. H. Loh, H. Li, F. Lau, W. Ebina, P. K. Mandal, Z. D. Smith, A. Meissner, G. Q. Daley, A. S. Brack, J. J. Collins, C. Cowan, T. M. Schlaeger and D. J. Rossi: Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7, 618-630 (2010)
17. K. Woltjen, I. P. Michael, P. Mohseni, R. Desai, M. Mileikovsky, R. Hamalainen, R. Cowling, W. Wang, P. Liu, M. Gertsenstein, K. Kaji, H. K. Sung and A. Nagy: piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 458, 766-770 (2009)
18. B. Feng, J. H. Ng, J. C. Heng and H. H. Ng: Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell, 4, 301-312 (2009)
19. Y. Li, Q. Zhang, X. Yin, W. Yang, Y. Du, P. Hou, J. Ge, C. Liu, W. Zhang, X. Zhang, Y. Wu, H. Li, K. Liu, C. Wu, Z. Song, Y. Zhao, Y. Shi and H. Deng: Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res, 21, 196-204 (2010)
20. A. Prochiantz: Protein and peptide transduction, twenty years later a happy birthday. Adv Drug Deliv Rev, 60, 448-451 (2008) (Pubitemid 351215571)
21. H. Zhou, S. Wu, J. Y. Joo, S. Zhu, D. W. Han, T. Lin, S. Trauger, G. Bien, S. Yao, Y. Zhu, G. Siuzdak, H. R. Scholer, L. Duan and S. Ding: Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4, 381-384 (2009)
22. D. Kim, C. H. Kim, J. I. Moon, Y. G. Chung, M. Y. Chang, B. S. Han, S. Ko, E. Yang, K. Y. Cha, R. Lanza and K. S. Kim: Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 4, 472-476 (2009)
23. H. Wichterle, I. Lieberam, J. A. Porter and T. M. Jessell: Directed differentiation of embryonic stem cells into motor neurons. Cell, 110, 385-397 (2002)
24. S. H. Lee, N. Lumelsky, L. Studer, J. M. Auerbach and R. D. McKay: Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol, 18, 675-679 (2000) (Pubitemid 30415305)
25. T. Wataya, S. Ando, K. Muguruma, H. Ikeda, K. Watanabe, M. Eiraku, M. Kawada, J. Takahashi, N. Hashimoto and Y. Sasai: Minimization of exogenous signals in ES cell culture induces rostral hypothalamic differentiation. Proc Natl Acad Sci U S A, 105, 11796-11801 (2008)
26. N. Gaspard, T. Bouschet, A. Herpoel, G. Naeije, J. van den Ameele and P. Vanderhaeghen: Generation of cortical neurons from mouse embryonic stem cells. Nat Protoc, 4, 1454-1463 (2009)
27. G. Makri, A. A. Lavdas, L. Katsimpardi, P. Charneau, D. Thomaidou and R. Matsas: Transplantation of embryonic neural stem/precursor cells overexpressing BM88/Cend1 enhances the generation of neuronal cells in the injured mouse cortex. Stem Cells, 28, 127-139 (2010)
28. B. Y. Hu, J. P. Weick, J. Yu, L. X. Ma, X. Q. Zhang, J. A. Thomson and S. C. Zhang: Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A, 107, 4335-4340 (2010)
29. J. T. Dimos, K. T. Rodolfa, K. K. Niakan, L. M. Weisenthal, H. Mitsumoto, W. Chung, G. F. Croft, G. Saphier, R. Leibel, R. Goland, H. Wichterle, C. E. Henderson and K. Eggan: Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321, 1218-1221 (2008)
30. S. Karumbayaram, B. G. Novitch, M. Patterson, J. A. Umbach, L. Richter, A. Lindgren, A. E. Conway, A. T. Clark, S. A. Goldman, K. Plath, M. Wiedau-Pazos, H. I. Kornblum and W. E. Lowry: Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells, 27, 806-811 (2009)
31. F. Soldner, D. Hockemeyer, C. Beard, Q. Gao, G. W. Bell, E. G. Cook, G. Hargus, A. Blak, O. Cooper, M. Mitalipova, O. Isacson and R. Jaenisch: Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 136, 964-977 (2009)
32. H. Zeng, M. Guo, K. Martins-Taylor, X. Wang, Z. Zhang, J. W. Park, S. Zhan, M. S. Kronenberg, A. Lichtler, H. X. Liu, F. P. Chen, L. Yue, X. J. Li and R. H. Xu: Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells. PLoS One, 5, e11853 (2011)
33. M. C. Marchetto, G. W. Yeo, O. Kainohana, M. Marsala, F. H. Gage and A. R. Muotri: Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One, 4, e7076 (2009)
34. T. Vierbuchen, A. Ostermeier, Z. P. Pang, Y. Kokubu, T. C. Sudhof and M. Wernig: Direct conversion of fibroblasts to functional neurons by defined factors. Nature, 463, 1035-1041 (2010)
35. D. Bohl, S. Liu, S. Blanchard, M. Hocquemiller, G. Haase and J. M. Heard: Directed evolution of motor neurons from genetically engineered neural precursors. Stem Cells, 26, 2564-2575 (2008)
36. R. Banerjee, M. F. Beal and B. Thomas: Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci, 33, 541-549 (2010)
37. J. H. Kordower, T. B. Freeman, B. J. Snow, F. J. Vingerhoets, E. J. Mufson, P. R. Sanberg, R. A. Hauser, D. A. Smith, G. M. Nauert, D. P. Perl and et al.: Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med, 332, 1118-1124 (1995)
38. O. Lindvall, P. Brundin, H. Widner, S. Rehncrona, B. Gustavii, R. Frackowiak, K. L. Leenders, G. Sawle, J. C. Rothwell, C. D. Marsden and et al.: Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science, 247, 574-577 (1990)
39. P. Brundin, R. A. Barker and M. Parmar: Neural grafting in Parkinson's disease Problems and possibilities. Prog Brain Res, 184, 265-294 (2010)
40. J. Y. Li, E. Englund, J. L. Holton, D. Soulet, P. Hagell, A. J. Lees, T. Lashley, N. P. Quinn, S. Rehncrona, A. Bjorklund, H. Widner, T. Revesz, O. Lindvall and P. Brundin: Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med, 14, 501-503 (2008) (Pubitemid 351655211)
41. L. J. Fisher, H. A. Jinnah, L. C. Kale, G. A. Higgins and F. H. Gage: Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-dopa. Neuron, 6, 371-380 (1991)
42. Z. Zou, X. Jiang, W. Zhang, Y. Zhou, Y. Ke, S. Zhang and R. Xu: Efficacy of Tyrosine Hydroxylase gene modified neural stem cells derived from bone marrow on Parkinson's disease-A rat model study. Brain Res, 1346, 279-286 (2010)
43. S. U. Kim, I. H. Park, T. H. Kim, K. S. Kim, H. B. Choi, S. H. Hong, J. H. Bang, M. A. Lee, I. S. Joo, C. S. Lee and Y. S. Kim: Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease. Neuropathology, 26, 129-140 (2006)
44. S. Park, E. Y. Kim, G. S. Ghil, W. S. Joo, K. C. Wang, Y. S. Kim, Y. J. Lee and J. Lim: Genetically modified human embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease. Neurosci Lett, 353, 91-94 (2003) (Pubitemid 37510188)
45. M. B. Rosenberg, T. Friedmann, R. C. Robertson, M. Tuszynski, J. A. Wolff, X. O. Breakefield and F. H. Gage: Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression. Science, 242, 1575-1578 (1988) (Pubitemid 19023703)
46. A. Glavaski-Joksimovic, T. Virag, T. A. Mangatu, M. McGrogan, X. S. Wang and M. C. Bohn: Glial cell linederived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease. J Neurosci Res, 88, 2669-2681 (2010)
47. Q. J. Li, Y. M. Tang, J. Liu, D. Y. Zhou, X. P. Li, S. H. Xiao, D. X. Jian and Y. G. Xing: Treatment of Parkinson disease with C17.2 neural stem cells overexpressing NURR1 with a recombined republic-deficit adenovirus containing the NURR1 gene. Synapse, 61, 971-977 (2007) (Pubitemid 350271776)
48. C. L. Parish, G. Castelo-Branco, N. Rawal, J. Tonnesen, A. T. Sorensen, C. Salto, M. Kokaia, O. Lindvall and E. Arenas: Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J Clin Invest, 118, 149-160 (2008)
49. D. Mitrecic, C. Nicaise, S. Gajovic and R. Pochet: Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis. Cell Transplant, 19, 537-548 (2010)
50. L. Mazzini, I. Ferrero, V. Luparello, D. Rustichelli, M. Gunetti, K. Mareschi, L. Testa, A. Stecco, R. Tarletti, M. Miglioretti, E. Fava, N. Nasuelli, C. Cisari, M. Massara, R. Vercelli, G. D. Oggioni, A. Carriero, R. Cantello, F. Monaco and F. Fagioli: Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp Neurol, 223, 229-237 (2010)
51. L. Mazzini, K. Mareschi, I. Ferrero, E. Vassallo, G. Oliveri, N. Nasuelli, G. D. Oggioni, L. Testa and F. Fagioli: Stem cell treatment in Amyotrophic Lateral Sclerosis. J Neurol Sci, 265, 78-83 (2008)
52. M. Suzuki, J. McHugh, C. Tork, B. Shelley, A. Hayes, I. Bellantuono, P. Aebischer and C. N. Svendsen: Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther, 16, 2002-2010 (2008)
53. S. M. Klein, S. Behrstock, J. McHugh, K. Hoffmann, K. Wallace, M. Suzuki, P. Aebischer and C. N. Svendsen: GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther, 16, 509-521 (2005) (Pubitemid 40647148)
54. M. Suzuki, J. McHugh, C. Tork, B. Shelley, S. M. Klein, P. Aebischer and C. N. Svendsen: GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS ONE, 2, e689 (2007)
55. C. Nicaise, D. Mitrecic and R. Pochet: Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells. Neuropathol Appl Neurobiol, 37, 179-178 (2011)
56. A. A. Rizvanov, D. S. Guseva, Salafutdinov, II, N. V. Kudryashova, F. V. Bashirov, A. P. Kiyasov, M. E. Yalvac, I. M. Gazizov, M. S. Kaligin, F. Sahin, M. A. Mukhamedyarov, A. Palotas and R. R. Islamov: Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice. Exp Biol Med (Maywood), 236, 91-98 (2011)
57. R. J. Armstrong, C. Watts, C. N. Svendsen, S. B. Dunnett and A. E. Rosser: Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplant, 9, 55-64 (2000) (Pubitemid 30438906)
58. O. Isacson, S. B. Dunnett and A. Bjorklund: Graftinduced behavioral recovery in an animal model of Huntington disease. Proc Natl Acad Sci U S A, 83, 2728-2732 (1986) (Pubitemid 16026957)
59. A. C. Bachoud-Levi, P. Remy, J. P. Nguyen, P. Brugieres, J. P. Lefaucheur, C. Bourdet, S. Baudic, V. Gaura, P. Maison, B. Haddad, M. F. Boisse, T. Grandmougin, R. Jeny, P. Bartolomeo, G. Dalla Barba, J. D. Degos, F. Lisovoski, A. M. Ergis, E. Pailhous, P. Cesaro, P. Hantraye and M. Peschanski: Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet, 356, 1975-1979 (2000)
60. I. Madrazo, R. E. Franco-Bourland, H. Castrejon, C. Cuevas and F. Ostrosky-Solis: Fetal striatal homotransplantation for Huntington's disease: first two case reports. Neurol Res, 17, 312-315 (1995)
61. A. Martinez-Serrano and A. Bjorklund: Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J Neurosci, 16, 4604-4616 (1996) (Pubitemid 26251057)
62. N. D. Dey, M. C. Bombard, B. P. Roland, S. Davidson, M. Lu, J. Rossignol, M. I. Sandstrom, R. L. Skeel, L. Lescaudron and G. L. Dunbar: Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease. Behav Brain Res, 214, 193-200 (2010)
63. J. H. Kordower, E. Y. Chen, C. Winkler, R. Fricker, V. Charles, A. Messing, E. J. Mufson, S. C. Wong, J. M. Rosenstein, A. Bjorklund, D. F. Emerich, J. Hammang and M. K. Carpenter: Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington's disease. J Comp Neurol, 387, 96-113 (1997) (Pubitemid 27419462)
64. A. Martinez-Serrano and A. Bjorklund: Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging. Proc Natl Acad Sci U S A, 95, 1858-1863 (1998) (Pubitemid 28103484)
65. M. Blurton-Jones, M. Kitazawa, H. Martinez-Coria, N. A. Castello, F. J. Muller, J. F. Loring, T. R. Yamasaki, W. W. Poon, K. N. Green and F. M. LaFerla: Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A, 106, 13594-13599 (2009)
66. C. D. Keene, R. C. Chang, A. H. Lopez-Yglesias, B. R. Shalloway, I. Sokal, X. Li, P. J. Reed, L. M. Keene, K. S. Montine, R. M. Breyer, J. K. Rockhill and T. J. Montine: Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow. Am J Pathol, 177, 346-354 (2010)
67. J. J. Ohab and S. T. Carmichael: Poststroke neurogenesis: emerging principles of migration and localization of immature neurons. Neuroscientist, 14, 369-380 (2008) (Pubitemid 352010071)
68. P. Ramos-Cabrer, C. Justicia, D. Wiedermann and M. Hoehn: Stem cell mediation of functional recovery after stroke in the rat. PLoS One, 5, e12779 (2010)
69. J. Ding, Y. Cheng, S. Gao and J. Chen: Effects of nerve growth factor and Noggin-modified bone marrow stromal cells on stroke in rats. J Neurosci Res, 89, 222-230 (2011)
70. T. Nomura, O. Honmou, K. Harada, K. Houkin, H. Hamada and J. D. Kocsis: I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience, 136, 161-169 (2005) (Pubitemid 41483844)
71. B. Chen, X. Q. Gao, C. X. Yang, S. K. Tan, Z. L. Sun, N. H. Yan, Y. G. Pang, M. Yuan, G. J. Chen, G. T. Xu, K. Zhang and Q. L. Yuan: Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Res, 1284, 1-11 (2009)
72. Z. H. Zhang, R. Z. Wang, G. L. Li, J. J. Wei, Z. J. Li, M. Feng, J. Kang, W. C. Du, W. B. Ma, Y. N. Li, Y. Yang and Y. G. Kong: Transplantation of neural stem cells modified by human neurotrophin-3 promotes functional recovery after transient focal cerebral ischemia in rats. Neurosci Lett, 444, 227-230 (2008)
73. G. W. Cho, S. H. Koh, M. H. Kim, A. R. Yoo, M. Y. Noh, S. Oh and S. H. Kim: The neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke. Brain Res, 1353, 1-13 (2010)
74. T. Onda, O. Honmou, K. Harada, K. Houkin, H. Hamada and J. D. Kocsis: Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab, 28, 329-340 (2008) (Pubitemid 351161284)
75. H. Liu, O. Honmou, K. Harada, K. Nakamura, K. Houkin, H. Hamada and J. D. Kocsis: Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain, 129, 2734-2745 (2006) (Pubitemid 44522106)
76. W. Wu, X. Chen, C. Hu, J. Li, Z. Yu and W. Cai: Transplantation of neural stem cells expressing hypoxiainducible factor-1alpha (HIF-1alpha) improves behavioral recovery in a rat stroke model. J Clin Neurosci, 17, 92-95 (2010)
77. S. S. Kim, S. W. Yoo, T. S. Park, S. C. Ahn, H. S. Jeong, J. W. Kim, D. Y. Chang, K. G. Cho, S. U. Kim, Y. Huh, J. E. Lee, S. Y. Lee, Y. D. Lee and H. Suh-Kim: Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem Cells, 26, 2217-2228 (2008)
78. M. Hayase, M. Kitada, S. Wakao, Y. Itokazu, K. Nozaki, N. Hashimoto, Y. Takagi and M. Dezawa: Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke. J Cereb Blood Flow Metab, 29, 1409-1420 (2009)
79. T. Yasuhara, N. Matsukawa, K. Hara, M. Maki, M. M. Ali, S. J. Yu, E. Bae, G. Yu, L. Xu, M. McGrogan, K. Bankiewicz, C. Case and C. V. Borlongan: Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev, 18, 1501-1514 (2009)
80. S. U. Kim: Genetically engineered human neural stem cells for brain repair in neurological diseases. Brain Dev, 29, 193-201 (2007) (Pubitemid 46283285)
81. K. Pollock, P. Stroemer, S. Patel, L. Stevanato, A. Hope, E. Miljan, Z. Dong, H. Hodges, J. Price and J. D. Sinden: A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp Neurol, 199, 143-155 (2006) (Pubitemid 43959830)
82. H. J. Lee, I. J. Lim, M. C. Lee and S. U. Kim: Human neural stem cells genetically modified to overexpress brainderived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model. J Neurosci Res, 88, 3282-3294 (2010)
83. H. J. Lee, K. S. Kim, I. H. Park and S. U. Kim: Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS One, 2, e156 (2007)
84. M. E. Schwab: Nogo and axon regeneration. Curr Opin Neurobiol, 14, 118-124 (2004) (Pubitemid 38264581)
85. P. Lu and M. H. Tuszynski: Growth factors and combinatorial therapies for CNS regeneration. Exp Neurol, 209, 313-320 (2008) (Pubitemid 351174138)
86. R. Grill, K. Murai, A. Blesch, F. H. Gage and M. H. Tuszynski: Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J Neurosci, 17, 5560-5572 (1997)
87. L. Klimaschewski, N. Obermuller and R. Witzgall: Regulation of clusterin expression following spinal cord injury. Cell Tissue Res, 306, 209-216 (2001) (Pubitemid 32972379)
88. H. Okano, M. Sakaguchi, K. Ohki, N. Suzuki and K. Sawamoto: Regeneration of the central nervous system using endogenous repair mechanisms. J Neurochem, 102, 1459-1465 (2007) (Pubitemid 47256201)
89. J. Chen, C. Bernreuther, M. Dihne and M. Schachner: Cell adhesion molecule l1-transfected embryonic stem cells with enhanced survival support regrowth of corticospinal tract axons in mice after spinal cord injury. J Neurotrauma, 22, 896-906 (2005) (Pubitemid 41153874)
90. A. Karabay, W. Yu, J. M. Solowska, D. H. Baird and P. W. Baas: Axonal growth is sensitive to the levels of katanin, a protein that severs microtubules. J Neurosci, 24, 5778-5788 (2004) (Pubitemid 38857232)
91. S. Y. Fu and T. Gordon: The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol, 14, 67-116 (1997) (Pubitemid 127720197)
92. V. Suarez, O. Guntinas-Lichius, M. Streppel, S. Ingorokva, M. Grosheva, W. F. Neiss, D. N. Angelov and L. Klimaschewski: The axotomy-induced neuropeptides galanin and pituitary adenylate cyclase-activating peptide promote axonal sprouting of primary afferent and cranial motor neurones. Eur J Neurosci, 24, 1555-1564 (2006) (Pubitemid 44427524)
93. K. Haastert, Z. Ying, C. Grothe and F. Gomez-Pinilla: The effects of FGF-2 gene therapy combined with voluntary exercise on axonal regeneration across peripheral nerve gaps. Neurosci Lett, 443, 179-183 (2008)
94. W. Heine, K. Conant, J. W. Griffin and A. Hoke: Transplanted neural stem cells promote axonal regeneration through chronically denervated peripheral nerves. Exp Neurol, 189, 231-240 (2004) (Pubitemid 39221818)
95. Q. Cao, Q. He, Y. Wang, X. Cheng, R. M. Howard, Y. Zhang, W. H. DeVries, C. B. Shields, D. S. Magnuson, X. M. Xu, D. H. Kim and S. R. Whittemore: Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury. J Neurosci, 30, 2989-3001 (2010)
96. H. Levkovitch-Verbin, O. Sadan, S. Vander, M. Rosner, Y. Barhum, E. Melamed, D. Offen and S. Melamed: Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection. Invest Ophthalmol Vis Sci, 51, 6394-6400 (2010)
97. K. S. Aboody, A. Brown, N. G. Rainov, K. A. Bower, S. Liu, W. Yang, J. E. Small, U. Herrlinger, V. Ourednik, P. M. Black, X. O. Breakefield and E. Y. Snyder: Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A, 97, 12846-12851 (2000)
98. R. L. Yong, N. Shinojima, J. Fueyo, J. Gumin, G. G. Vecil, F. C. Marini, O. Bogler, M. Andreeff and F. F. Lang: Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas. Cancer Res, 69, 8932-8940 (2009)
99. R. Uchibori, T. Okada, T. Ito, M. Urabe, H. Mizukami, A. Kume and K. Ozawa: Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy. J Gene Med, 11, 373-381 (2009)
100. P. V. Dickson, J. B. Hamner, R. A. Burger, E. Garcia, A. A. Ouma, S. U. Kim, C. Y. Ng, J. T. Gray, K. S. Aboody, M. K. Danks and A. M. Davidoff: Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-beta and restricts tumor growth in a murine model of disseminated neuroblastoma. J Pediatr Surg, 42, 48-53 (2007) (Pubitemid 46037712)
101. M. van Eekelen, L. S. Sasportas, R. Kasmieh, S. Yip, J. L. Figueiredo, D. N. Louis, R. Weissleder and K. Shah: Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors. Oncogene, 29, 3185-3195 (2010)
102. A. P. Kyritsis, C. Sioka and J. S. Rao: Viruses, gene therapy and stem cells for the treatment of human glioma. Cancer Gene Ther, 16, 741-752 (2009)
103. K. M. Kroeger, A. K. Muhammad, G. J. Baker, H. Assi, M. K. Wibowo, W. Xiong, K. Yagiz, M. Candolfi, P. R. Lowenstein and M. G. Castro: Gene therapy and virotherapy: novel therapeutic approaches for brain tumors. Discov Med, 10, 293-304 (2010)
104. M. J. Brodie and P. Kwan: Staged approach to epilepsy management. Neurology, 58, S2-8 (2002) (Pubitemid 34415365)
105. M. W. Nolte, W. Loscher, C. Herden, W. J. Freed and M. Gernert: Benefits and risks of intranigral transplantation of GABA-producing cells subsequent to the establishment of kindling-induced seizures. Neurobiol Dis, 31, 342-354 (2008)
106. D. Boison: Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells. Neurotherapeutics, 6, 278-283 (2009)
107. M. Guttinger, D. Fedele, P. Koch, V. Padrun, W. F. Pralong, O. Brustle and D. Boison: Suppression of kindled seizures by paracrine adenosine release from stem cellderived brain implants. Epilepsia, 46, 1162-1169 (2005) (Pubitemid 41647752)
108. D. H. Hwang, H. J. Lee, I. H. Park, J. I. Seok, B. G. Kim, I. S. Joo and S. U. Kim: Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther, 16, 1234-1244 (2009)
109. S. Park, H. T. Kim, S. Yun, I. S. Kim, J. Lee, I. S. Lee and K. I. Park: Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice. Exp Mol Med, 41, 487-500 (2009)